Gliadel
Drug Neurology
NDC 24338-050-08
General payments
$29,244
Research payments
$302,809
Through program year 2023, $29,244 in general payments and $302,809 in research payments were reported against Gliadel (Neurology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | General | $5,161 | 275 |
| 2023 | Research | $80,926 | 31 |
| 2022 | General | $8,355 | 274 |
| 2022 | Research | $129,070 | 52 |
| 2021 | General | $12,796 | 411 |
| 2021 | Research | $92,813 | 36 |
| 2020 | General | $2,933 | 173 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2023.
The top 5 of 32 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.
The top 5 of 28 states; each share is of general payments naming this product in 2023 where a state was reported.
Records
1,133 general · 119 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.